Your browser doesn't support javascript.
loading
The PRMT5 inhibitor EPZ015666 is effective against HTLV-1-transformed T-cell lines in vitro and in vivo.
Ernzen, Kyle; Melvin, Corrine; Yu, Lianbo; Phelps, Cameron; Niewiesk, Stefan; Green, Patrick L; Panfil, Amanda R.
Afiliação
  • Ernzen K; Department of Veterinary Biosciences, Center for Retrovirus Research, The Ohio State University, Columbus, OH, United States.
  • Melvin C; Department of Veterinary Biosciences, Center for Retrovirus Research, The Ohio State University, Columbus, OH, United States.
  • Yu L; Department of Biomedical Informatics, College of Public Health, The Ohio State University, Columbus, OH, United States.
  • Phelps C; Department of Veterinary Biosciences, Center for Retrovirus Research, The Ohio State University, Columbus, OH, United States.
  • Niewiesk S; Department of Veterinary Biosciences, Center for Retrovirus Research, The Ohio State University, Columbus, OH, United States.
  • Green PL; Comprehensive Cancer Center and Solove Research Institute, The Ohio State University, Columbus, OH, United States.
  • Panfil AR; Department of Veterinary Biosciences, Center for Retrovirus Research, The Ohio State University, Columbus, OH, United States.
Front Microbiol ; 14: 1101544, 2023.
Article em En | MEDLINE | ID: mdl-36819050
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Microbiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Microbiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos